| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.830 | Human |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.772 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.743 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.729 | |
| amine metabolic process | GO:0009308 | 45 | 0.725 | |
| steroid metabolic process | GO:0008202 | 119 | 0.710 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.703 | |
| lipid localization | GO:0010876 | 126 | 0.681 | |
| lipid homeostasis | GO:0055088 | 63 | 0.662 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.657 | |
| lipid storage | GO:0019915 | 36 | 0.640 | Human |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.620 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.605 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.596 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.589 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.588 | |
| cellular homeostasis | GO:0019725 | 240 | 0.587 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.544 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.536 | |
| sterol metabolic process | GO:0016125 | 58 | 0.525 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.523 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.520 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.516 | |
| oxidation reduction process | GO:0055114 | 342 | 0.516 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.498 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.481 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.462 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.451 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.435 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.433 | |
| lipid transport | GO:0006869 | 98 | 0.420 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.415 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.391 | |
| low density lipoprotein particle remodeling | GO:0034374 | 2 | 0.379 | Human |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.338 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.335 | |
| sterol homeostasis | GO:0055092 | 45 | 0.313 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.295 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.295 | |
| gland development | GO:0048732 | 330 | 0.293 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.290 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.287 | |
| cation homeostasis | GO:0055080 | 212 | 0.286 | |
| innate immune response | GO:0045087 | 157 | 0.278 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.271 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.265 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.263 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.246 | Human |
| response to metal ion | GO:0010038 | 47 | 0.243 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.235 | |
| protein oxidation | GO:0018158 | 2 | 0.232 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.228 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.223 | |
| inflammatory response | GO:0006954 | 244 | 0.221 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.216 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.210 | |
| response to stilbenoid | GO:0035634 | 22 | 0.207 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.206 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.205 | |
| response to oxidative stress | GO:0006979 | 123 | 0.204 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.201 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.197 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.196 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.189 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.186 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.185 | |
| organic hydroxy compound catabolic process | GO:1901616 | 25 | 0.184 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.182 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.182 | |
| transmembrane transport | GO:0055085 | 412 | 0.182 | |
| anion transport | GO:0006820 | 177 | 0.180 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.180 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.179 | |
| immune effector process | GO:0002252 | 321 | 0.173 | |
| regulation of system process | GO:0044057 | 200 | 0.173 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.170 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.169 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.169 | |
| organic anion transport | GO:0015711 | 137 | 0.168 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.168 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.167 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.166 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.163 | |
| maintenance of location | GO:0051235 | 89 | 0.162 | Human |
| regulation of body fluid levels | GO:0050878 | 162 | 0.161 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.153 | |
| wound healing | GO:0042060 | 157 | 0.153 | |
| cell adhesion | GO:0007155 | 329 | 0.152 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.150 | |
| lipid catabolic process | GO:0016042 | 69 | 0.149 | |
| regulation of cell motility | GO:2000145 | 236 | 0.148 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.148 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.146 | |
| cholesterol efflux | GO:0033344 | 24 | 0.146 | |
| cytokine production | GO:0001816 | 319 | 0.144 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.144 | |
| diacylglycerol biosynthetic process | GO:0006651 | 2 | 0.144 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.144 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.142 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.140 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.139 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.138 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.138 | |
| angiogenesis | GO:0001525 | 201 | 0.138 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.138 | |
| intestinal absorption | GO:0050892 | 13 | 0.137 | |
| defense response to other organism | GO:0098542 | 197 | 0.136 | |
| chemotaxis | GO:0006935 | 247 | 0.136 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.133 | |
| blood coagulation | GO:0007596 | 76 | 0.132 | |
| endocrine system development | GO:0035270 | 98 | 0.130 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.128 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.127 | |
| organ or tissue specific immune response | GO:0002251 | 13 | 0.126 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.126 | |
| response to oxygen levels | GO:0070482 | 62 | 0.126 | |
| sterol transmembrane transport | GO:0035382 | 2 | 0.125 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.125 | |
| response to drug | GO:0042493 | 75 | 0.124 | |
| regulation of secretion | GO:0051046 | 274 | 0.122 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.122 | |
| lipid modification | GO:0030258 | 65 | 0.122 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.120 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.119 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.119 | |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.117 | |
| regulation of cell migration | GO:0030334 | 219 | 0.117 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.116 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.116 | |
| response to nutrient levels | GO:0031667 | 109 | 0.115 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.114 | |
| endothelial cell proliferation | GO:0001935 | 27 | 0.114 | |
| response to inorganic substance | GO:0010035 | 96 | 0.113 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.112 | |
| triglyceride rich lipoprotein particle remodeling | GO:0034370 | 2 | 0.112 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.111 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.111 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.110 | |
| protein lipid complex remodeling | GO:0034368 | 6 | 0.110 | Human |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.110 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.109 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.109 | |
| fibrinolysis | GO:0042730 | 3 | 0.109 | |
| innate immune response in mucosa | GO:0002227 | 3 | 0.109 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.108 | |
| tissue migration | GO:0090130 | 68 | 0.107 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.107 | |
| very low density lipoprotein particle remodeling | GO:0034372 | 1 | 0.104 | |
| regulation of protein localization | GO:0032880 | 231 | 0.103 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.102 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.102 | |
| t cell proliferation | GO:0042098 | 120 | 0.101 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.101 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.100 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.099 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.099 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.099 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.099 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.097 | |
| regulation of defense response | GO:0031347 | 233 | 0.097 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.097 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.097 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.096 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.095 | |
| hexose metabolic process | GO:0019318 | 98 | 0.095 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.094 | |
| oxidative demethylation | GO:0070989 | 1 | 0.094 | |
| cholesterol biosynthetic process | GO:0006695 | 15 | 0.094 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.093 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.092 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.092 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.091 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.091 | |
| digestion | GO:0007586 | 40 | 0.090 | |
| cholesterol transport | GO:0030301 | 38 | 0.090 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.090 | |
| response to hypoxia | GO:0001666 | 58 | 0.089 | |
| epithelial cell migration | GO:0010631 | 63 | 0.089 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.089 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.089 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.089 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.088 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.088 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.087 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.087 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.086 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.086 | Human |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.086 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.086 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.084 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.084 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.084 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.083 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.083 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.083 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.082 | |
| sterol biosynthetic process | GO:0016126 | 17 | 0.082 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.082 | |
| steroid esterification | GO:0034433 | 3 | 0.082 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.081 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.081 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.080 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.080 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.079 | |
| cholesterol esterification | GO:0034435 | 3 | 0.079 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.078 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.078 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.077 | |
| mucosal immune response | GO:0002385 | 13 | 0.076 | |
| hemostasis | GO:0007599 | 78 | 0.076 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.076 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.075 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.075 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.074 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.074 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.074 | |
| epithelium migration | GO:0090132 | 63 | 0.073 | |
| medium chain fatty acid metabolic process | GO:0051791 | 1 | 0.073 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.072 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.072 | |
| regulation of protein transport | GO:0051223 | 163 | 0.072 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.071 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.071 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.071 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.070 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.070 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.070 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.070 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.069 | |
| coagulation | GO:0050817 | 78 | 0.069 | |
| protein glycosylation | GO:0006486 | 55 | 0.069 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.069 | |
| mapk cascade | GO:0000165 | 281 | 0.069 | |
| forebrain development | GO:0030900 | 302 | 0.068 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.068 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.068 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.068 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.067 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.067 | |
| blood circulation | GO:0008015 | 195 | 0.067 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.067 | |
| endothelial cell migration | GO:0043542 | 44 | 0.067 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.066 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.066 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.066 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.066 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.066 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.065 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.065 | |
| fat cell differentiation | GO:0045444 | 160 | 0.064 | |
| myosin filament assembly | GO:0031034 | 2 | 0.064 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.063 | |
| drug metabolic process | GO:0017144 | 4 | 0.063 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.063 | |
| regulation of protein processing | GO:0070613 | 96 | 0.062 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.062 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.062 | |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.062 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.062 | |
| glial cell differentiation | GO:0010001 | 131 | 0.061 | |
| regulation of digestive system process | GO:0044058 | 13 | 0.061 | |
| regulation of cytokine production involved in immune response | GO:0002718 | 26 | 0.061 | |
| telencephalon development | GO:0021537 | 186 | 0.061 | |
| locomotory behavior | GO:0007626 | 195 | 0.061 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.061 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.060 | |
| respiratory tube development | GO:0030323 | 167 | 0.060 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.060 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.060 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.060 | |
| glycolytic process | GO:0006096 | 20 | 0.060 | |
| circulatory system process | GO:0003013 | 197 | 0.059 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.059 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.059 | |
| sterol catabolic process | GO:0016127 | 5 | 0.059 | |
| epithelial cell development | GO:0002064 | 159 | 0.059 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.058 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.058 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.058 | |
| transforming growth factor beta receptor signaling pathway involved in primitive streak formation | GO:0090010 | 1 | 0.058 | |
| epidermis development | GO:0008544 | 187 | 0.058 | |
| response to peptide hormone | GO:0043434 | 127 | 0.058 | |
| glial cell development | GO:0021782 | 54 | 0.057 | |
| liver development | GO:0001889 | 66 | 0.057 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.057 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.057 | |
| protein methylation | GO:0006479 | 81 | 0.057 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.056 | |
| lung development | GO:0030324 | 164 | 0.056 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.056 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.056 | |
| regulation of cell activation | GO:0050865 | 289 | 0.056 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.055 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.055 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.055 | |
| response to acid chemical | GO:0001101 | 111 | 0.055 | |
| gluconeogenesis | GO:0006094 | 39 | 0.055 | |
| cellular response to lipid | GO:0071396 | 145 | 0.055 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.055 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.055 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.055 | |
| protein secretion | GO:0009306 | 111 | 0.054 | |
| cellular response to follicle stimulating hormone stimulus | GO:0071372 | 1 | 0.054 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.054 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.054 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.054 | |
| triglyceride homeostasis | GO:0070328 | 15 | 0.053 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.053 | |
| adaptive immune response | GO:0002250 | 155 | 0.053 | |
| myosin filament organization | GO:0031033 | 3 | 0.052 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.052 | |
| sterol esterification | GO:0034434 | 3 | 0.052 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.051 | |
| phospholipid transport | GO:0015914 | 21 | 0.051 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.051 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.051 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.051 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.050 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.050 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.050 | |
| long chain fatty acid metabolic process | GO:0001676 | 26 | 0.050 | |
| dna metabolic process | GO:0006259 | 303 | 0.050 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.050 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.050 | |
| gliogenesis | GO:0042063 | 141 | 0.050 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.049 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.049 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.049 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.049 | |
| carbohydrate transport | GO:0008643 | 62 | 0.048 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.048 | |
| negative regulation of fibrinolysis | GO:0051918 | 1 | 0.048 | |
| gastrulation | GO:0007369 | 116 | 0.048 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.047 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.047 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.047 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.047 | |
| negative regulation of growth | GO:0045926 | 99 | 0.047 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.046 | |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.046 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.046 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.046 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.046 | |
| positive regulation of hemostasis | GO:1900048 | 10 | 0.045 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.045 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.045 | |
| placenta development | GO:0001890 | 140 | 0.044 | |
| phosphatidylcholine metabolic process | GO:0046470 | 13 | 0.044 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.044 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.044 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.044 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.044 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.043 | |
| hormone secretion | GO:0046879 | 128 | 0.043 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.043 | |
| axonogenesis | GO:0007409 | 274 | 0.043 | |
| regulation of cytokine secretion involved in immune response | GO:0002739 | 4 | 0.043 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.043 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.043 | |
| response to monosaccharide | GO:0034284 | 67 | 0.043 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.042 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.042 | |
| cation transport | GO:0006812 | 399 | 0.042 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.042 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.042 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.042 | |
| regulation of ion transport | GO:0043269 | 215 | 0.041 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.041 | |
| protein processing | GO:0016485 | 163 | 0.041 | |
| cytokine secretion | GO:0050663 | 72 | 0.041 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.041 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.041 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.040 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.040 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.040 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.040 | |
| digestive tract development | GO:0048565 | 190 | 0.040 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.040 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.040 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.040 | |
| tissue remodeling | GO:0048771 | 102 | 0.040 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.040 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.039 | |
| alcohol catabolic process | GO:0046164 | 16 | 0.039 | |
| alpha amino acid biosynthetic process | GO:1901607 | 15 | 0.039 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.039 | |
| negative regulation of serine type endopeptidase activity | GO:1900004 | 2 | 0.039 | |
| protein catabolic process | GO:0030163 | 221 | 0.039 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.039 | |
| peptide transport | GO:0015833 | 133 | 0.039 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.039 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.039 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.039 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.039 | |
| renal system development | GO:0072001 | 225 | 0.038 | |
| dna endoreduplication | GO:0042023 | 4 | 0.038 | |
| embryonic placenta development | GO:0001892 | 98 | 0.038 | |
| regionalization | GO:0003002 | 337 | 0.038 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.038 | |
| endothelium development | GO:0003158 | 45 | 0.037 | |
| amide transport | GO:0042886 | 138 | 0.037 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.037 | |
| regulation of anion transport | GO:0044070 | 27 | 0.037 | |
| response to starvation | GO:0042594 | 65 | 0.037 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.037 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.037 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.037 | |
| protein maturation | GO:0051604 | 176 | 0.036 | |
| smad protein signal transduction | GO:0060395 | 21 | 0.036 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.036 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.036 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.036 | |
| pallium development | GO:0021543 | 120 | 0.036 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.036 | |
| leukocyte migration | GO:0050900 | 124 | 0.036 | |
| cholesterol import | GO:0070508 | 2 | 0.036 | |
| skeletal system development | GO:0001501 | 356 | 0.036 | |
| cell fate commitment | GO:0045165 | 210 | 0.036 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.036 | |
| arachidonic acid metabolic process | GO:0019369 | 14 | 0.036 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.036 | |
| anion homeostasis | GO:0055081 | 16 | 0.036 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.036 | |
| negative regulation of iron ion transport | GO:0034757 | 1 | 0.035 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.035 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.035 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.035 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.035 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.035 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.035 | |
| dibenzo p dioxin metabolic process | GO:0018894 | 1 | 0.034 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.034 | |
| high density lipoprotein particle assembly | GO:0034380 | 3 | 0.034 | |
| response to chromate | GO:0046687 | 1 | 0.034 | |
| multicellular organism growth | GO:0035264 | 161 | 0.034 | |
| negative regulation of coagulation | GO:0050819 | 11 | 0.034 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.033 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.033 | |
| activation of immune response | GO:0002253 | 138 | 0.033 | |
| ovulation cycle | GO:0042698 | 59 | 0.033 | |
| response to insulin | GO:0032868 | 100 | 0.033 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.033 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.033 | |
| cellular phosphate ion homeostasis | GO:0030643 | 2 | 0.033 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.033 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.033 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.033 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.033 | |
| regulation of substrate adhesion dependent cell spreading | GO:1900024 | 12 | 0.033 | |
| steroid catabolic process | GO:0006706 | 7 | 0.033 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.033 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.032 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.032 | |
| cytokine secretion involved in immune response | GO:0002374 | 6 | 0.032 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.032 | |
| cholesterol catabolic process | GO:0006707 | 5 | 0.032 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.032 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.031 | |
| regulation of serine type endopeptidase activity | GO:1900003 | 2 | 0.031 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.031 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.031 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.031 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.031 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.031 | |
| muscle tissue development | GO:0060537 | 308 | 0.031 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.031 | |
| reverse cholesterol transport | GO:0043691 | 6 | 0.031 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.031 | |
| collagen fibril organization | GO:0030199 | 32 | 0.031 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.031 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.031 | |
| naphthalene metabolic process | GO:0018931 | 1 | 0.031 | |
| sterol import | GO:0035376 | 2 | 0.031 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.031 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.031 | |
| salivary gland morphogenesis | GO:0007435 | 33 | 0.031 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.031 | |
| male gamete generation | GO:0048232 | 285 | 0.031 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.030 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.030 | |
| glycosylation | GO:0070085 | 62 | 0.030 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.030 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.030 | |
| peptide secretion | GO:0002790 | 114 | 0.030 | |
| striated muscle cell development | GO:0055002 | 125 | 0.030 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.030 | |
| bone morphogenesis | GO:0060349 | 78 | 0.030 | |
